Financials
- Market Capitalization 1.78 B
- Employee 377
- Founded 2014
- CEO John Leonard
- Website www.intelliatx.com
- Headquarter Delaware, United States
- FIGI BBG007KC7PB0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.07
ratio cours/chiffre d'affaires
32.42
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2070 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2072 | INBX Inhibrx Biosciences, Inc. - Common Stock | 122.74 USD | -0.54% | +22.74% | +49.94% | +52.32% | 1.81 B USD | ||
| 2087 | SEPN Septerna, Inc. - Common Stock | 38.15 USD | -1.95% | -8.23% | +10.74% | +73.33% | 1.78 B USD | ||
| 2106 | FTRE Fortrea Holdings Inc. - Common Stock | 18.37 USD | -2.34% | +0.22% | -4.52% | +90.56% | 1.75 B USD |